Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Feb 14 04:00PM ET
105.43
Dollar change
-2.28
Percentage change
-2.12
%
Index- P/E17.95 EPS (ttm)5.87 Insider Own0.00% Shs Outstand1.98B Perf Week-0.78%
Market Cap208.23B Forward P/E12.34 EPS next Y8.54 Insider Trans- Shs Float1.98B Perf Month6.42%
Income11.94B PEG3.04 EPS next Q2.02 Inst Own6.63% Short Float0.21% Perf Quarter0.49%
Sales50.32B P/S4.14 EPS this Y5.51% Inst Trans-1.74% Short Ratio2.66 Perf Half Y-7.13%
Book/sh22.30 P/B4.73 EPS next Y3.66% ROA11.34% Short Interest4.08M Perf Year6.43%
Cash/sh6.81 P/C15.47 EPS next 5Y5.90% ROE26.33% 52W Range92.35 - 120.92 Perf YTD8.34%
Dividend Est.3.89 (3.69%) P/FCF12.81 EPS past 5Y13.99% ROI17.83% 52W High-12.81% Beta0.55
Dividend TTM3.74 (3.55%) Quick Ratio0.84 Sales past 5Y1.74% Gross Margin74.07% 52W Low14.16% ATR (14)1.78
Dividend Ex-DateMar 07, 2024 Current Ratio1.04 EPS Y/Y TTM-17.73% Oper. Margin30.62% RSI (14)54.75 Volatility1.29% 1.43%
Employees75883 Debt/Eq0.71 Sales Y/Y TTM1.08% Profit Margin23.73% Recom2.89 Target Price114.89
Option/ShortYes / Yes LT Debt/Eq0.52 EPS Q/Q-65.76% Payout44.73% Rel Volume0.83 Prev Close107.71
Sales Surprise2.45% EPS Surprise9.73% Sales Q/Q15.14% EarningsJan 31 BMO Avg Volume1.53M Price105.43
SMA201.29% SMA504.33% SMA200-1.82% Trades Volume1,267,793 Change-2.12%
Date Action Analyst Rating Change Price Target Change
Feb-13-25Downgrade UBS Buy → Neutral
Feb-12-25Initiated Morgan Stanley Underweight
Feb-04-25Upgrade Deutsche Bank Hold → Buy
Dec-04-24Downgrade HSBC Securities Hold → Reduce
Sep-11-24Downgrade BofA Securities Buy → Neutral $135 → $130
Sep-05-24Downgrade Goldman Buy → Neutral
Sep-03-24Downgrade Jefferies Buy → Hold
Jul-19-24Downgrade Deutsche Bank Buy → Hold
May-30-24Initiated Goldman Buy $120
Feb-23-24Initiated BMO Capital Markets Market Perform $114
Feb-14-25 06:52AM
04:33AM
Feb-12-25 01:40PM
Feb-11-25 06:40AM
05:00AM
01:41AM Loading…
01:41AM
01:15AM
Feb-10-25 01:55PM
Feb-06-25 01:06PM
09:50AM
02:45AM
02:45AM
Feb-05-25 10:13AM
09:40AM
03:00AM
08:32AM Loading…
Feb-03-25 08:32AM
Feb-01-25 12:33PM
02:03AM
Jan-31-25 04:08PM
01:00PM
10:19AM
09:30AM
08:44AM
06:49AM
06:26AM
05:10AM
04:40AM
01:14AM
01:00AM
Jan-30-25 07:00PM
06:43AM Loading…
Jan-28-25 06:43AM
Jan-22-25 03:00AM
Jan-16-25 04:07PM
12:09PM
03:56AM
Jan-15-25 07:01PM
Jan-14-25 04:57PM
Jan-13-25 01:00PM
01:15AM
Jan-10-25 08:30AM
07:38AM
Jan-07-25 09:40AM
Jan-03-25 05:45AM
Jan-02-25 06:34AM
Dec-31-24 09:45AM
06:28AM
03:34AM
Dec-30-24 12:45AM
Dec-28-24 04:57PM
Dec-27-24 11:19AM
Dec-23-24 01:50PM
Dec-19-24 07:12AM
05:46AM
05:20AM
Dec-18-24 08:45AM
07:45AM
Dec-17-24 09:40AM
Dec-10-24 09:00AM
Dec-09-24 05:18AM
Dec-08-24 12:30PM
Dec-06-24 01:15AM
Dec-04-24 09:45AM
07:15AM
Dec-03-24 09:17AM
04:42AM
Dec-02-24 04:21PM
12:58PM
12:40PM
11:29AM
07:47AM
07:00AM
05:56AM
Dec-01-24 03:45PM
Nov-30-24 07:05PM
04:17PM
Nov-27-24 10:25AM
01:15AM
Nov-26-24 06:55AM
Nov-25-24 01:15AM
Nov-23-24 10:24AM
Nov-22-24 06:41AM
04:09AM
Nov-21-24 10:17AM
06:50AM
06:48AM
01:00AM
Nov-19-24 08:00AM
07:45AM
06:35AM
Nov-18-24 08:00AM
12:44AM
Nov-15-24 12:40PM
09:40AM
08:46AM
Nov-14-24 09:35AM
Nov-13-24 09:55AM
09:35AM
08:37AM
06:56AM
06:15AM
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment includes researching, distributing and selling patented pharmaceuticals. The Sandoz segment focuses on marketing finished dosage form medicines and intermediary products including active pharmaceutical ingredients. The Corporate segment is involved in group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kowalski Robert WilliamOfficerAug 12 '24Proposed Sale111.726,566733,572Aug 12 03:30 PM